z-logo
open-access-imgOpen Access
Dual-Specificity Phosphatase 3 Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis
Author(s) -
Lucia Musumeci,
Marijke J. E. Kuijpers,
Karen Gilio,
Alexandre Hego,
Emilie Théâtre,
L.F.A. Maurissen,
Maud Vandereyken,
Cátia V. Diogo,
Christelle Lecut,
William Guilmain,
Ekaterina V. Bobkova,
Johannes A. Eble,
Russell Dahl,
Pierre Drion,
Justin Rascon,
Yalda Mostofi,
Qiang Yu,
Eduard Sergienko,
Thomas D.Y. Chung,
Marc Thiry,
Yotis A. Senis,
Michel Moutschen,
Tomas Mustelin,
Patrizio Lancellotti,
Johan W. M. Heemskerk,
Lutz Tautz,
Cécile Oury,
Souad Rahmouni
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.010186
Subject(s) - medicine , thrombosis , platelet activation , platelet , cardiology
A limitation of current antiplatelet therapies is their inability to separate thrombotic events from bleeding occurrences. A better understanding of the molecular mechanisms leading to platelet activation is important for the development of improved therapies. Recently, protein tyrosine phosphatases have emerged as critical regulators of platelet function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom